Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
hydroxychloroquine (plaquenil) (1 trial)
imatinib (gleevec) (1 trial)
infliximab (remicade) (2 trials)
naltrexone (revia) (1 trial)
prednisone (meticorten) (1 trial)
remdesivir (Veklury) (1 trial)
sulfasalazine (azulfidine) (1 trial)
bortezomib (velcade) (1 trial)
urea (1 trial)
cabazitaxel (jevtana kit) (1 trial)
ertapenem (invanz) (2 trials)
moxifloxacin (avelox) (1 trial)
rimabotulinumtoxinB (Myobloc) (1 trial)
Arthritis (Phase 4)
Arthritis, Rheumatoid (Phase 4)
Multiple Myeloma (Phase 3)
Prostatic Neoplasms (Phase 2)
Trials (8 total)
Trial APIs (13 total)